the female to male ratio 5,5:1 in the north and 2:1 in the south. Time period from the first symptoms occurence to the RA diagnosis was 17.7 (13.2) months for the northern part and 25.0 (16.9) for the southern; 20.6 (14.9) for Serbia; in that period patients were mostly treated with NSAIDS (82%) and physical therapy (30%); short-lasting corticosteroids were given to 13%, peroral corticosteroids to 4% and no patients were treated with DMARDS. (SD 6.7), 32 had depression/anxiety, and mean sleep duration was 6.63 hours (SD 1.4). 12 months after TKF there were significant improvements in WOMAC dimension scores (mean >25 points, p<0.001) and SF-36 scores (mean >19). At study inclusion, 23% reported RS with a mean sleep duration of 7.5 hours (SD 1.1) vs. 6.24 hours (SD 1.5) in NRS patients (p=0.002). 12 months after TKR, 40% of patients had RS (p=0.029). Patients with RS had better scores in all quality of life dimensions (<10 points) than those with NRS (p<0.05) at baseline and at 12 months. Multivariate analysis showed RS was independently associated with pain and function 
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the female to male ratio 5,5:1 in the north and 2:1 in the south. Time period from the first symptoms occurence to the RA diagnosis was 17.7 (13.2) months for the northern part and 25.0 (16.9) for the southern; 20.6 (14.9) for Serbia; in that period patients were mostly treated with NSAIDS (82%) and physical therapy (30%); short-lasting corticosteroids were given to 13%, peroral corticosteroids to 4% and no patients were treated with DMARDS. Conclusions: RA prevalence in the southern and northern part of Serbia is in line (0.42% [95% CI 0.12;0.72]) vs 0.30% [95% CI 0.09;0.51]), being more frequently presented in females as compared to males (five times more in the north and two times more in the south). Delay in diagnosis as compared to the first symptoms occurence was 21 months and during that time no patients were treated with DMARDS. (SD 6.7) , 32 had depression/anxiety, and mean sleep duration was 6.63 hours (SD 1.4). 12 months after TKF there were significant improvements in WOMAC dimension scores (mean >25 points, p<0.001) and SF-36 scores (mean >19). At study inclusion, 23% reported RS with a mean sleep duration of 7.5 hours (SD 1.1) vs. 6.24 hours (SD 1.5) in NRS patients (p=0.002). 12 months after TKR, 40% of patients had RS (p=0.029). Patients with RS had better scores in all quality of life dimensions (<10 points) than those with NRS (p<0.05) at baseline and at 12 months. Multivariate analysis showed RS was independently associated with pain and function (WOMAC and SF-36) (p<0.007). Conclusions: Sleep health was associated with better HRQL before and after TKR. Although more patients had RS after TKR, 60% of patients continued not to have sleep health. Although often undervalued clinically, sleep health is closely associated with the health status. Acknowledgements: This work was funded by project PI/13/00948, integrated in the Plan Nacional I+D+I and cofounded by ISCIII-Subdirección General de Evaluación and European Regional Development Fund (ERDF). However, rheumatic diseases have not yet been thoroughly investigated in terms of association with birth month. Objectives: In this study, we sought to determine whether birth month or season could affect the risk of rheumatologic diseases. Methods: The birth month patterns of patients with rheumatic diseases were compared with to those of general population. We utilized the claims data of Health Insurance Review and Assessment Service (HIRA) which covers nearly 90% of total population in Korea. The associations between birth month/season and 32 diseases were investigated using logistic regression. Results: Our dataset included 17,247,458 (male 8,224,670; female 9,022,788) individuals from HIRA database from January, 1997 to August, 2015. Among 27 rheumatic diseases, 8 diseases including Crohn's disease (CD), ulcerative colitis (UC), rheumatoid arthritis (RA), systemic lupus erythematosus, polymyalgia rheumatica (PMR), ankylosing spondylitis (AS), multiple sclerosis, gout, fibromyalgia (FMS) were significantly associated with birth month (P<0.05). In terms of seasonality, CD, UC, RA, Sjogren's syndrome, PMR, AS, Gout, and FMS demonstrated significant difference. CD, UC and AS showed higher prevalence in individuals born in winter and lower prevalence in summer. On the other hand, people who were born in summer showed higher possibility to have gout and FMS compared to those born in winter. In consistent with previous reports, type 1 diabetes is more prevalent in those born in winter. Angina and myocardial infarction showed higher prevalence in patients born in spring and lower in fall. This consistency reflects the relevance of our dataset and methodology. Conclusions: We found significant impacts of birth month/season on various rheumatic diseases. Seasonal variation of infective agents, sun exposure or food ingestion during gestation or early infancy may explain the association between birth month/season and certain disease development. Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most common cause of drug hypersensitivity reactions (DHR). Recent studies show that the prevalence of hypersensitivity reaction to drug is particularly in Poland. Objectives: To assess the frequency and the risk od developing NSAID hypersensitivity in patients with chronic disorders of the musculoskeletal system. Methods: The study group consisted of 200 patients (age 19-88 years -54,5±14, women-161, men-39) hospitalized in the Department of Rheumatology in 2015-2016. All patients filled questionnaire regarding symptoms of DHR after ingestion of non-steroidal anti-inflammatory drugs. The presence of DHR, clinical pattern of the reaction, frequency of NSAIDs administration and comorbidities have been studied. In statistical studies the main risk factors were defined. Results: Seventy-seven patients from study group (38,5%) reported symptoms that occurred within 24 hours after NSAIDs ingestion. Symptoms characteristic for hypersensitivity reaction were reported by 40 patients (20%). Respiratory symptoms like dyspnea and/or cough were reported by 22 patients (11%). Cutaneous symptoms (urticaria/angioedema/dermal flush) were reported also by 29 patients (14,5%). Three patients experienced loss of consciousness. Thirty-seven patients reported isolated stomach cramps. The symptoms developed usually between 2-12 hours after drug intake. In 37 patients oral administration caused DHR reaction, moreover in 14 patients also topical application led to adverse reaction. In most of patients reaction appeared due to COX-1 inhibitor and interestingly in 3 patients reaction was evoked by celecoxib which is perceived to be safe alternative for patients with NSAIDs hypersensitivity. Chronic urticaria, asthma and systematic drug intake occurs the main risk factors of hypersensitivity. Conclusions: Drug hypersensitivity reactions are reported very frequently in population of patients with chronic musculoskeletal disorders. Our studies suggest that patients taking protractedly NSAIDs are in group with high risk of drug hypersensitivity development. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.5408 
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